2BB score and signals
Spero Therapeutics, Inc.’s current 2BB score is 25 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 4 | Very Low |
| Momentum | 55 | Stable |
| Financial strength | 61 | Strong |
| Quality | 40 | Normal |
| Risk | 42 | Moderate |
Spero Therapeutics, Inc. (SPRO) Stock Score & Signals
Spero Therapeutics, Inc. (SPRO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 25 out of 100.
Company facts
| Founded | 2013 |
| Employees | 25 |
| P/E ratio | 29.42 |
| 52-week range | $1.08 – $3.08 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-24 | — | -0.1428 | — | — |
| 2026-11-11 | — | -0.1428 | — | — |
| 2026-08-12 | — | -0.1734 | — | — |
| 2026-05-13 | -0.13 | -0.1836 | $260,000.00 | — |